Minsoo Byun

Title: Minsoo Byun: Innovator in Biopharmaceuticals

Introduction

Minsoo Byun is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative methods and products that enhance therapeutic efficacy.

Latest Patents

Minsoo Byun holds 5 patents that showcase his expertise and innovative spirit. His latest patents include a method for producing recombinant hyaluronidase, which involves altering N-glycan levels under specific culture conditions. This method not only increases the specific activity by 10% or more but also improves the quality and production yield of hyaluronidase. Another notable patent is an antibody-drug conjugate comprising a modified antibody. This invention features a modified antibody with a specific structural motif that enhances the conjugation yield of the drug, thereby improving therapeutic outcomes.

Career Highlights

Minsoo Byun is currently associated with Alteogen, Inc., where he continues to push the boundaries of biopharmaceutical innovation. His work has been instrumental in advancing the understanding and application of antibody-drug conjugates and recombinant enzymes.

Collaborations

Throughout his career, Minsoo has collaborated with esteemed colleagues, including Soon Jae Park and Hye-Shin Chung. These collaborations have further enriched his research and development efforts in the biopharmaceutical sector.

Conclusion

Minsoo Byun's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in therapeutic technologies.